|
|
||||||||
Transcription1
Immunology Group, Department of Cell and Molecular Biology, Lund University, Lund, Sweden
By mutational analysis of the octamer-TATA box intervening region
in the mouse SP6
promoter, we have mapped two octamer-dependent,
costimulatory regions, A and B. The A region was active in late B cells
only, while the B region was active throughout B cell differentiation.
The B region was TATA proximal and contained a heptamer and an E box of
the E2A type that is common in V
promoters. Mutation of the heptamer
element did not decrease transcriptional stimulation from this region,
but mutations in, or immediately 5' of, the E box core sequence did. A
protein binding to this region could be detected in nuclear extracts.
The complex could only partially be competed with a µE5 binding site
and could not be supershifted with Abs raised to E2A gene products,
indicating that it may represent a novel E-box binding complex. The A
region was located proximal to the octamer and contained a CCCT element
that is conserved both with regard to position and sequence in human
V
II promoters. By mutational analysis, the transcriptional
stimulatory activity was mapped to the CCCT element that also is part
of an early B cell factor (EBF) binding site. In late B cells, a novel
protein (FA), which did not bind to the EBF binding site in the mb1
promoter, interacted with the A region. This protein was found to be
expressed at lower levels in early B cells as well as in HeLa cells.
Thus, the octamer-flanking sequence contains positive control elements
that may act independently but that differ in the stage of B cell
differentiation at which they are active. One of these factors is an
example of an ubiquitously expressed transcription factor that
participate in differentiation-specific transcriptional activation.
This article has been cited by other articles:
![]() |
H. Lindgren, K. Axcrona, and T. Leanderson Regulation of Transcriptional Activity of the Murine CD40 Ligand Promoter in Response to Signals Through TCR and the Costimulatory Molecules CD28 and CD2 J. Immunol., April 1, 2001; 166(7): 4578 - 4585. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Akerblad, M. Rosberg, T. Leanderson, and M. Sigvardsson The B29 (Immunoglobulin beta -Chain) Gene Is a Genetic Target for Early B-Cell Factor Mol. Cell. Biol., January 1, 1999; 19(1): 392 - 401. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |